Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥70.0bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥137.4bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥68.4bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥3.5bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥3.7bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥3.5bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥6.7bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.5bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥3.8bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥3.5bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥68.9bnat 2025-09-30Cons.Assets
Total assets¥70.1bnat 2025-03-31Cons.Assets
Total assets¥70.5bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥45.0bnat 2025-09-30Cons.Liabilities
Total liabilities¥47.4bnat 2025-03-31Cons.Liabilities
Net assets / equity¥23.9bnat 2025-09-30Cons.Net assets
Net assets / equity¥22.7bnat 2025-03-31Cons.Net assets
Net assets / equity¥21.5bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥11.0bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥14.0bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥11.0bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥12.3bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥15.1bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥1.0bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥5.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥381m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥113m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥347m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥720m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.9bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.3bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥25.62025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.942024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.992024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio34.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.4%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio30.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥3m
Children Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥5.3bn
Children Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥5.3bn
Children Businessreportable segmentsegment profit2025-04-01 → 2025-09-30−¥39m
Elderly Care Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥28.1bn
Elderly Care Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥28.1bn
Elderly Care Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥1.5bn
Medical Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥36.6bn
Medical Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥36.6bn
Medical Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.1bn
—segment totalrevenue2025-04-01 → 2025-09-30¥70.0bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥70.0bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥4m
Children Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥5.0bn
Children Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.0bn
Children Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥78m
Elderly Care Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥27.8bn
Elderly Care Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥27.8bn
Elderly Care Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥35.5bn
Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥35.5bn
Medical Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.3bn
—segment totalrevenue2024-04-01 → 2024-09-30¥68.4bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥68.4bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 475
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任 あずさ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)今 井 仁 子
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)西垣内 琢 也
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1InterimDuration68388000000JPY
Net sales (5-year summary)InterimDuration70033000000JPY
Net sales (5-year summary)Prior1YearDuration137435000000JPY
Ordinary income loss (5-year summary)Prior1InterimDuration3455000000JPY
Ordinary income loss (5-year summary)InterimDuration3517000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration6726000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1InterimDuration1935000000JPY
Profit loss attributable to owners of parent (5-year summary)InterimDuration2360000000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration3960000000JPY
Comprehensive income (5-year summary)Prior1InterimDuration1923000000JPY
Comprehensive income (5-year summary)InterimDuration2351000000JPY
Comprehensive income (5-year summary)Prior1YearDuration4001000000JPY
Net assets (5-year summary)Prior1InterimInstant21529000000JPY
Net assets (5-year summary)InterimInstant23905000000JPY
Net assets (5-year summary)Prior1YearInstant22684000000JPY
Total assets (5-year summary)Prior1InterimInstant70496000000JPY
Total assets (5-year summary)InterimInstant68875000000JPY
Total assets (5-year summary)Prior1YearInstant70097000000JPY
Basic earnings loss per share (5-year summary)Prior1InterimDuration20.99
Basic earnings loss per share (5-year summary)InterimDuration25.60
Basic earnings loss per share (5-year summary)Prior1YearDuration42.94
Diluted earnings per share (5-year summary)Prior1InterimDuration-
Diluted earnings per share (5-year summary)InterimDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1InterimInstant0.305
Equity to asset ratio (5-year summary)InterimInstant0.347
Equity to asset ratio (5-year summary)Prior1YearInstant0.324
Net cash provided by used in operating activities (5-year summary)Prior1InterimDuration381000000JPY
Net cash provided by used in operating activities (5-year summary)InterimDuration1043000000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration5877000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1InterimDuration720000000JPY
Net cash provided by used in investing activities (5-year summary)InterimDuration-113000000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration347000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1InterimDuration-3912000000JPY
Net cash provided by used in financing activities (5-year summary)InterimDuration-3944000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-7335000000JPY
Cash and cash equivalents (5-year summary)Prior1InterimInstant12305000000JPY
Cash and cash equivalents (5-year summary)InterimInstant10989000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant14004000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember94741793
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember94741793
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant94741793
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant94741793
Number of shares heldInterimInstant_No1MajorShareholdersMember31805100
Shareholding ratioInterimInstant_No1MajorShareholdersMember0.3464

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass